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Tuberculosis remains a severe public health problem worldwide. Presently, genotyping is used for conducting epidemiologic and 
clinical studies on tuberculosis cases. We evaluated the efficacy of the repetitive sequence-based PCR (rep-PCR)-based DiversiLab
TM 
system (bioMérieux, France) over the IS6110-restriction fragment length polymorphism analysis for detecting Mycobacterium tu-
berculosis. In all, 89 clinical M. tuberculosis isolates collected nationwide from Korea were used. The DiversiLab system allocated the 
89 isolates to 8 groups with 1 unique isolate when a similarity level of 95% was applied. Seventy-six isolates of the Beijing family 
and 13 isolates of non-Beijing family strains were irregularly distributed regardless of rep-PCR groups. The DiversiLab system gen-
erated a rapid, sensitive, and standardized result. It can be used to conduct molecular epidemiologic studies to identify clinical M. 
tuberculosis isolates in Korea.
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Tuberculosis (TB) remains a severe public health prob-
lem worldwide. In Korea, the prevalence of TB is still high 
despite multiple efforts to combat it [1, 2]. In addition, there 
has been a steady increase in the incidence of strains becom-
ing resistant to drugs [3]. Genotyping is necessary for epi-
demiologic and clinical purposes and improves the under-
standing of the epidemiology and control of TB by provid-
ing information about transmission [4]. An epidemiologic 
tool, repetitive sequence-based PCR (rep-PCR), has been 
recognized as an effective method [5]. Rep-PCR is used to 
determine the similarity of bacterial strains at the genomic 
level as the repetitive sequences throughout the genome en-
able discrimination of interstrain variation on the basis of 
amplicon size and intensity. Rep-PCR greatly enhances as-
say reproducibility and strain discrimination compared with 
other PCR-based platforms. The commercial DiversiLab
TM 
Microbial Typing System (bioMérieux, Marcy l’Etoile, France) 
[6] has the advantage of real-time data production and the 
convenience of partial automation [7]. IS6110-based restric-
tion fragment length polymorphism (RFLP) is considered 
the gold standard and the most widely applied genotyping 
method for the molecular epidemiology of Mycobacterium 
tuberculosis [8].
In this study, we evaluated the DiversiLab rep-PCR-based 
system’s discriminatory ability for M. tuberculosis by com-Jang MH, et al.  •  Automated rep-PCR for M. tuberculosis
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paring it with previous data from IS6110-RFLP analysis [9]. 
We studied 89 clinical M. tuberculosis isolates collected from 
11 university hospitals nationwide in Korea between 2008 
and 2009 from epidemiologically unrelated patients. All 89 
isolates had already been characterized by IS6110-RFLP [9]. 
According to the manufacturer’s recommendations, the Di-
versiLab Fingerprinting Kit (Bacterial Barcodes, Inc., Hus-
ton, TX, USA) was used for rep-PCR amplification of non-
coding intergenic repetitive elements in the genomic DNA 
of the isolates. Rep-PCR genomic typing was performed us-
ing the DiversiLab system. The DiversiLab system includes 
fragment separation using microfluidic chips (LabChip de-
vice; Caliper Technologies, Inc., Mountain View, CA, USA) 
and the Agilent B2100 Bioanalyzer (Agilent Technologies 
Inc., Palo Alto, CA, USA). Results were analyzed using Di-
versiLab software (version 3.3). Reports, including dendro-
grams, electropherograms, and virtual gel and scatterplot 
images, were generated automatically. To evaluate repro-
ducibility, we performed the entire assay, including DNA 
extraction, PCR, and chip analysis on the bioanalyzer, in 
duplicate. The percent similarities of the dendrograms were 
analyzed by Pearson correlation. We used a single numeri-
cal index of discrimination on the basis of Simpson’s index 
of diversity [10].
The results of the DiversiLab system defined 89 isolates in 
8 groups and 1 unique isolate when a similarity level of 95% 
was applied (Fig. 1). One major group contained 18 isolates. 
Seventy-six isolates of the Beijing family and 13 isolates of 
non-Beijing family strains, previously defined by IS6110-
RFLP [1], were distributed to each group. Therefore, this 
method was able to discriminate strain variations between 
Beijing family members. Among the 14 isolates of the K fa-
mily, which showed unique RFLP patterns and are rather 
highly prevalent in Korea, 7 (50%) belonged to 1 major group. 
The reproducibility studies showed identical rep-PCR pat-
terns for each duplicate test with the same strain. The results 
of cluster analysis did not correlate with any region of strain 
isolation.
Few publications are available on the performance of the 
DiversiLab system [11-13]. Cangelosi et al. [14] evaluated 
the system as an epidemiologic method for M. tuberculosis 
and M. avium complex, indicating that it can replace IS6110-
RFLP for typing M. tuberculosis. In our current study, we 
showed the usefulness of the DiversiLab system by evaluat-
ing its efficacy with 89 M. tuberculosis isolates collected na-
tionwide in Korea. The system displayed highly discrimina-
tory results among Beijing family strains that have shown 
nearly identical IS6110-RFLP patterns. IS6110-RFLP is con-
sidered a gold standard method in strain typing for M. tu-
berculosis; however, discrimination of the Beijing family is 
unsatisfactory by using this method [15]. Therefore, IS6110-
RFLP is less useful in Korea, where Beijing family strains are 
highly prevalent (87 to 95%) [9, 16]. The DiversiLab system 
can be a surrogate tool for epidemiologic analysis of M. tu-
berculosis in Korea. The ability to generate fingerprints in 
real time, together with the DNA amplification step, enables 
analysis in the early stages of the event; i.e., suspected cross 
contamination or outbreak. 
Other molecular epidemiologic methods for M. tubercu-
losis strains have been evaluated. Mycobacterial interspersed 
repetitive units-variable number tandem repeats (MIRU-
Fig. 1. Comparison of rep-PCR results with IS6110-RFLP patterns for 89 clini-
cal Mycobacterium tuberculosis isolates. A scale for rep-PCR similarity (%) is 
shown at the bottom of the figure. IS6110-RFLP results are cited from refer-
ence 9. 
Abbreviations: RFLP, restriction fragment length polymorphism; NB, strains of 
non-Beijing family; B, strains of Beijing family; K, strains of K family.
Cluster
Rep-PCR Sample  
No.
IS6110-RFLP










   27  NB 
   80  B 
   97  B 
   93  B 
   94  B 
117  B 
112  NB 
   68  B 
118  B 
   38  B 
   37  B 
   52  B 
   21  B 
   58  B 
106  NB 
105  B 
   81  B 
   50  B  `
   18  B, K 
109  B, K 
   99  B, K 
111  B, K 
108  B, K 
   85  B, K 
120  B 
   26  B 
   53  B, K 
   22  NB 
100  B 
   82  B 
119  B 
   42  B 
   19  B 
   90  B 
   17  B, K 
   39  B 
   29  B 
   51  NB 
   25  B 
115  B 
101  B 
   76  B, K 
   91  B 
123  NB 
122  NB 
   54  B 
   23  B 
   61  NB 
   84  B 
   87  B 
   46  B 
   28  B 
   54  B 
   36  B, K 
   56  B 
   55  B 
   88  B, K 
   86  B, K 
   40  B 
   89  NB 
   47  B 
104  B, K 
   44  B 
   53  B 
   78  NB 
   55  B 
110  B, K 
   77  B 
   16  B 
   43  B 
107  B 
   92  B 
   35  B 
   32  B 
103  B 
102  B 
121  B 
   70  B 
   74  B 
   34  B 
   98  NB 
   48  B 
   24  B 
   62  B 
   57  B 
124  B 
   33  NB 
114  B 
   20  NB 
70 80 90 100284     www.kjlm.org
Jang MH, et al.  •  Automated rep-PCR for M. tuberculosis 
http://dx.doi.org/10.3343/kjlm.2011.31.4.282
KJLM
VNTR) is fairly rapid, requires only small amounts of DNA, 
and can easily be digitized to share data among laboratories 
[17]. Single-nucleotide polymorphism (SNP) analysis also 
provides a powerful strategy for large-scale molecular pop-
ulation studies examining phylogenetic relations among 
bacterial strains [18, 19]. However, the DiversiLab system 
provides results within 24 hr. Moreover, the DiversiLab sys-
tem can generate a sensitive and standardized result and is 
reproducible and highly discriminatory. Thus, it can be used 
in the molecular epidemiologic investigation of clinical M. 
tuberculosis isolates in Korea.
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